Skip to content
Search

Latest Stories

Over 700,000 illegal medicines seized in Northern Ireland

The illegal and unlicensed medicines worth approximately £785,000 were seized as part of Operation Pangea XVI 

The authority seized thousands of counterfeit and illicit prescription medicines destined for addresses throughout Northern Ireland.


A total of 712,000 illegal tablets and medicines with a street value of approximately £785,000 were intercepted, and 12 people were arrested, as reported by NewryTimes.

The medicines seized during Operation Pangea XVI include Zopiclone, Pregabalin, alprazolam (Xanax), Diazepam, Botox and weight-loss products.

The Medicines and Healthcare Products Regulatory Agency (MHRA) launched Operation Pangea 15 years ago to combat “illegal internet trade in medical” products.

Last month, the MHRA’s Criminal Enforcement Unit (CEU) revealed that it had seized more than two million “illegally traded medicines” this year, with a total value of £5 million.

Operation Pangea XVI is being jointly executed by law enforcement agencies and government departments.

Besides checking the illicit online supply of medicines, the operation also aims to inform the public about the significant health risks associated with buying medicines from illegal websites.

Richard Pengelly CB, Permanent Secretary, Department of Justice said that the Organised Crime Task Force (OCTF) drugs sub-group members have worked together to stop illicit medicines from reaching addresses in Northern Ireland.

“I very much welcome the outcome of this year’s Operation Pangea XVI and fully support all the partners in their efforts to tackle crime, to seize goods and criminal assets and protect public health,” he told NewryTimes.  

Peter May, Permanent Secretary of the Department of Health, commented that their participation in Operation Pangea is an important part of their continuing efforts to “reduce the harm that can be caused by illicit drugs and unregulated or counterfeit medicines.”

Noting that illegal suppliers do not follow quality control or legal standards, he urged the public “not to be tempted by what look like cut prices or professional looking websites offering medicines without a prescription.”

Detective Chief Superintendent Andy Hill, who heads the Police Service’s Organised Crime Branch, hailed the joint efforts of the Organised Crime Task Force for this huge seizure.

However, he pointed out that the figures also indicate “a worrying sign of the reality – and that’s the demand for and misuse of prescription drugs.”

Darren Brabon, Assistant Director of Border Force, added that the seizure of this substantial number of unlicensed medicines through “this fine example of joint working” ensures that these illicit medicines “won’t reach our streets and our communities remain protected.”

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less